CATALYST PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Catalyst Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q4 2024.
  • Catalyst Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 121M shares, a 12.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 121M +13.8M +12.8% Dec 31, 2024 10-K 2025-02-26
Q3 2024 119M +12.7M +11.9% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 119M +12M +11.3% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 118M +12.1M +11.4% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 107M +1.86M +1.77% Dec 31, 2023 10-K 2025-02-26
Q3 2023 107M +2.54M +2.44% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 107M +3.79M +3.69% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 106M +2.98M +2.9% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 105M +2.27M +2.2% Dec 31, 2022 10-K 2024-02-28
Q3 2022 104M +911K +0.88% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 103M -453K -0.44% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 103M -848K -0.82% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 103M -789K -0.76% Dec 31, 2021 10-K 2023-03-15
Q3 2021 103M -495K -0.48% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 103M -260K -0.25% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 104M +396K +0.38% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 104M +385K +0.37% Dec 31, 2020 10-K 2022-03-16
Q3 2020 104M +607K +0.59% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 103M +493K +0.48% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 103M +604K +0.59% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 103M +658K +0.64% Dec 31, 2019 10-K 2021-03-15
Q3 2019 103M +352K +0.34% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 103M +330K +0.32% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 103M +218K +0.21% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 103M +190K +0.19% Dec 31, 2018 10-K 2020-03-16
Q3 2018 103M +17.5M +20.5% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 103M +18M +21.3% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 103M +19.6M +23.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 103M +19.6M +23.6% Dec 31, 2017 10-K 2019-03-18
Q3 2017 85.2M +2.36M +2.85% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 84.6M +1.68M +2.03% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 83M +102K +0.12% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 83M +122K +0.15% Dec 31, 2016 10-K 2018-03-14
Q3 2016 82.9M +176K +0.21% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 82.9M +774K +0.94% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 82.9M +861K +1.05% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 82.9M +13.7M +19.9% Dec 31, 2015 10-K 2017-03-15
Q3 2015 82.7M +15.5M +23.1% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 82.1M +14.9M +22.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 82M +27.9M +51.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 69.1M +15M +27.7% Dec 31, 2014 10-K 2016-03-15
Q3 2014 67.2M +13.2M +24.4% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 67.2M +25.7M +62% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 54.1M +12.7M +30.7% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 54.1M +12.7M +30.7% Dec 31, 2013 10-K 2015-03-13
Q3 2013 54M +19.2M +55.4% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 41.5M +10.7M +34.9% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 41.4M +16.7M +67.4% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 41.4M +16.7M +67.7% Dec 31, 2012 10-K 2014-03-19
Q3 2012 34.7M +13.1M +60.4% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 30.7M +9.09M +42% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 24.7M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 24.7M +5.31M +27.4% Dec 31, 2011 10-K 2013-04-01
Q3 2011 21.7M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 21.7M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 19.4M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.